Early full enteral feeding for preterm or low birth weight infants by Walsh, Verena et al.
This is a repository copy of Early full enteral feeding for preterm or low birth weight infants.




Walsh, Verena, Brown, Jennifer Valeska Elli orcid.org/0000-0003-0943-5177, 
Copperthwaite, Bethany R et al. (2 more authors) (2020) Early full enteral feeding for 
preterm or low birth weight infants. Cochrane Database of Systematic Reviews. 





Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless 
indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by 
national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of 
the full text version. This is indicated by the licence information on the White Rose Research Online record 
for the item. 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 




Cochrane Database of Systematic Reviews
 
Early full enteral feeding for preterm or low birth weight infants
(Protocol)
 
  Walsh V, Brown JVE, Copperthwaite BR, Oddie SJ, McGuire W  
  Walsh V, Brown JVE, Copperthwaite BR, Oddie SJ, McGuire W. 
Early full enteral feeding for preterm or low birth weight infants. 




Early full enteral feeding for preterm or low birth weight infants (Protocol)
 








Cochrane Database of Systematic Reviews









CONTRIBUTIONS OF AUTHORS................................................................................................................................................................... 11
DECLARATIONS OF INTEREST..................................................................................................................................................................... 11
SOURCES OF SUPPORT............................................................................................................................................................................... 11
Early full enteral feeding for preterm or low birth weight infants (Protocol)









Cochrane Database of Systematic Reviews
[Intervention Protocol]
Early full enteral feeding for preterm or low birth weight infants
Verena Walsh1, Jennifer Valeska Elli Brown2, Bethany R Copperthwaite3, Sam J Oddie4, William McGuire1
1Centre for Reviews and Dissemination, University of York, York, UK. 2Mental Health and Addiction Research Group, Department of
Health Sciences, University of York, York, UK. 3Hull York Medical School, York, UK. 4Bradford Royal Infirmary, Bradford, UK
Contact address: William McGuire, Centre for Reviews and Dissemination, University of York, York, Y010 5DD, UK.
william.mcguire@york.ac.uk.
Editorial group: Cochrane Neonatal Group
Publication status and date: New, published in Issue 3, 2020.
Citation: Walsh V, Brown JVE, Copperthwaite BR, Oddie SJ, McGuire W. Early full enteral feeding for preterm or low birth weight infants.
Cochrane Database of Systematic Reviews 2020, Issue 3. Art. No.: CD013542. DOI: 10.1002/14651858.CD013542.
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A B S T R A C T
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
We aim to assess the benefits and harms of early full enteral nutrition versus progressive introduction of enteral feeds in preterm or low
birth weight (LBW) infants.
Where data are available, we will undertake subgroup analyses of very preterm or very low birth weight (VLBW) infants (versus infants born
aCer a longer gestation or with higher birth weight), infants who are 'small for gestational age' at birth (versus those deemed 'appropriate
for gestation'), infants fed with human milk only (versus formula-fed infants), and trials set in low- or middle-income countries (versus
high-income countries).
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B A C K G R O U N D
This Cochrane Review will appraise and synthesise data from
randomised controlled trials that compared early full enteral
feeding with delayed or gradual introduction of enteral feeds
(combined with parenteral fluids or nutrition) for preterm or low
birth weight infants.
Description of the condition
Preterm or low birth weight (LBW; less than 2500 g) infants,
especially very preterm or very low birth weight (VLBW: less
than 1500 g) infants, have few nutrient reserves at birth and are
subject to physiological and metabolic stresses that increase their
nutrient needs. Recommendations on nutrient requirements for
preterm or LBW infants assume that the optimal rate of postnatal
growth should be similar to that of uncompromised fetuses of an
equivalent gestational age (Tsang 1993; Agostoni 2010). Such levels
of nutrient input and growth are rarely achieved and most very
preterm or VLBW infants accumulate nutrient deficits during their
initial hospital stay (Embleton 2001; Horbar 2015). By the time they
are ready to go home, many of these infants are growth restricted
compared to their term-born peers (Clark 2003; Dusick 2003).
Growth deficits can persist through childhood and adolescence,
and are associated with adverse neurodevelopmental, cognitive,
and educational outcomes (Hack 1991; Ford 2000; Cooke 2003;
Doyle 2004; Farooqi 2006; Bracewell 2008; Leppänen 2014).
Necrotising enterocolitis
Necrotising enterocolitis (NEC), a syndrome of acute intestinal
necrosis of unknown aetiology, affects about one-in-twenty very
preterm or VLBW infants (Gagliardi 2008; Holman 1997; Moro
2009). Infants who develop NEC experience more infections, have
lower levels of nutrient intake, grow more slowly, and have longer
durations of intensive care and hospital stay than gestation-
comparable infants who do not develop NEC (Bisquera 2002;
Guthrie 2003). The associated mortality rate is greater than 20%
(Fitzgibbons 2009). Compared with their peers, infants who develop
NEC have a higher incidence of long-term neurological disability,
which may be a consequence of infection and undernutrition
during a critical period of brain development (Berrington 2012; Pike
2012; Rees 2007).
In addition to low gestational age at birth, the major risk factor for
NEC is intrauterine growth restriction, especially if it is associated
with absent or reversed end-diastolic flow velocities in Doppler
studies of the fetal aorta or umbilical artery (Dorling 2005; Samuels
2017). Most very preterm or VLBW infants who develop NEC have
received enteral milk feeds (Ramani 2013). Feeding with artificial
formula rather than human milk increases the risk of developing
NEC (Quigley 2019; Walsh 2019). However, the available data from
randomised controlled trials do not provide evidence that delaying
the introduction of progressive enteral feeds beyond four days aCer
birth, or advancing feed volumes more slowly than 24 mL/kg/day,
affects the risk of NEC and associated morbidities or mortality in
very preterm or VLBW infants (Morgan 2013; Morgan 2014; Oddie
2017).
Early enteral feeding strategies
Evidence exists that early enteral feeding strategies — particularly
the timing of introduction and the rate of advancement of milk
feeds — affect important outcomes in preterm or LBW infants,
including nutrient intake, the risk of NEC, and growth and
development (Embleton 2013). Approaches to early enteral feeding
vary by the gestational age and clinical condition of the infant
(Hay 2008; Klingenberg 2012). Stable preterm infants born at or
more than 32 weeks' gestation, or with a birth weight of 1500 g
or greater, are generally treated similarly to well term infants; all
fluid and nutrition is supplied enterally from birth, either orally
or via an intra-gastric feeding tube. In contrast, newborn infants
who are extremely preterm (born before 28 weeks' gestation) or of
extremely low birth weight (ELBW; less than 1000 g) are commonly
affected by respiratory distress, have delayed gastric emptying and
inefficient intestinal motility, and are at high risk of developing
NEC. These infants tend to be supported with parenteral fluids and
nutrition during the first few days aCer birth. Enteral milk feeds are
then introduced in sub-nutritional volumes (trophic feeds) during
the first week aCer birth, ideally as colostrum or expressed breast
milk, and the volume of feeds is increased gradually over the
next one to two weeks as the volume of parenteral nutrition is
decreased.
There remains substantial variation in practice with regard to
early enteral feeding strategies for those preterm infants born
at gestations between approximately 28 and 32 weeks (or with
birth weights between approximately 1000 g and 1500 g). This
variation reflects ongoing uncertainty about whether these infants
should be treated in the same way as those infants born at a
later gestation (that is, with full enteral feeds from birth), or
more similarly to extremely preterm or ELBW infants (that is,
delayed introduction and gradual advancement of milk feeds while
supporting nutritional needs with parenteral nutrition). In many
high-income countries, policy and practice has tended to favour the
conservative approach to introducing and advancing enteral feeds
for these infants because of concerns that early full enteral feeding
might increase the risk of feed intolerance, gastro-oesophageal
reflux and aspiration of stomach contents, hypoglycaemia, and NEC
in very preterm or VLBW infants (Maas 2018; Klingenberg 2012;
Leaf 2013; de Waard 2018). However, in low- and middle-income
countries with fewer resources for neonatal care, practice is more
pragmatic and tends to favour early introduction and advancement
of enteral feeds (sometimes facilitated by "kangaroo" mother care)
for stable infants born at 28 weeks' gestation or greater, or with a
birth weight of 1000 g or more (Sankar 2008; Conde-Agudelo 2016).
Description of the intervention
Early (sometimes termed "immediate") full enteral feeding means
that newborn infants receive all of their prescribed nutrition
as milk feeds (either human milk or formula) and do not
receive any supplemental parenteral fluids or nutrition from birth
(Nangia 2018). This approach for feeding preterm infants has
been advocated since the earliest days of modern neonatology
but has tended to be reserved for clinically stable preterm
infants of gestational age at birth of more than approximately 32
weeks (Smallpeice 1964; Klingenberg 2012). In most neonatal care
facilities, particularly in high-income countries, the more common
practice is to introduce enteral milk feeds for very preterm or
VLBW infants at low volume (trophic feeds or minimal enteral
nutrition) and to then advance the feed volume slowly during
the next one to two weeks. During this time, infants receive most
of their fluids and nutrition parenterally, usually in the form of
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commercially-available solutions containing amino acids, glucose,
minerals, vitamins, and fats (Klingenberg 2012).
There are potential disadvantages associated with conservative
enteral feeding regimens (Flidel-Rimon 2004; Flidel-Rimon 2006).
Because gastrointestinal hormone secretion and motility are
stimulated by milk feeds, delaying full enteral feeding may diminish
the functional adaptation of the gastrointestinal tract and disrupt
the patterns of microbial colonisation (Embleton 2017). Intestinal
dysmotility and dysbiosis might exacerbate feed intolerance and
delay the establishment of enteral feeding independently of
parenteral nutrition (Pammi 2017). Prolonging the duration of
parenteral nutrition is associated with infectious and metabolic
complications that increase mortality and morbidity, prolong
hospital stay, and adversely affect growth and development
(Embleton 2013). Due to cost and equipment implications,
parenteral nutrition is less easily available in low- and middle-
income countries. In high-income settings, earlier achievement
of full enteral feeds and an associated reduction of length of
hospital stay could be associated with considerable resource
savings (Embleton 2014).
How the intervention might work
The aims of early full enteral feeding are to avoid the risks and costs
associated with provision of parenteral nutrition and to accelerate
gastrointestinal physiological, endocrine and metabolic maturity
and so allow infants to attain nutrient intakes to optimise growth
and development. Early full enteral feeding in this vulnerable
population might reduce the risk of infection associated with
intravascular devices used to deliver parenteral nutrition (Flidel-
Rimon 2004). Early provision of breast milk might promote
successful expression and lactation and help establish maternal
breast milk feeding as the primary source of infant nutrition (Hay
2008; Senterre 2014). However, there is some concern that exclusive
enteral nutrition might not be sufficient to maintain normal blood
glucose levels during the early metabolic transition phase in
very preterm or VLBW infants, particularly in growth-restricted
infants with limited nutrient reserves at birth (Klingenberg 2012).
Furthermore, any beneficial effects may be negated if early full
enteral feeding increases the risk of feed intolerance or NEC in very
preterm or VLBW infants (Chauhan 2008; Samuels 2017).
Why it is important to do this review
This review is the first to focus on the comparison of early full
enteral feeding versus gradual introduction of progressive enteral
feeding in combination with parenteral fluids. Other Cochrane
Reviews have addressed the questions of whether delaying the
introduction of any enteral milk feeding or restricting feed volumes
to trophic levels (minimal enteral nutrition) affect the risk of NEC
in very preterm or VLBW infants (Morgan 2013; Morgan 2014). The
findings of this review will complement these existing reviews of
early enteral feeding strategies and might inform policy, practice,
or research in this field (Chauhan 2008).
O B J E C T I V E S
We aim to assess the benefits and harms of early full enteral
nutrition versus progressive introduction of enteral feeds in
preterm or low birth weight (LBW) infants.
Where data are available, we will undertake subgroup analyses
of very preterm or very low birth weight (VLBW) infants (versus
infants born aCer a longer gestation or with higher birth weight),
infants who are 'small for gestational age' at birth (versus those
deemed 'appropriate for gestation'), infants fed with human milk
only (versus formula-fed infants), and trials set in low- or middle-
income countries (versus high-income countries).
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised or quasi-randomised controlled trials, including
cluster-randomised controlled trials.
Types of participants
Infants that are preterm (born at less than 37 weeks' gestation) or
low birth weight (less than 2500 g).
Types of interventions
Intervention: full enteral feeds from birth without parenteral fluids
or nutrition. Early full enteral nutrition will be defined as sufficient
volumes of milk being fed orally or via a naso- or oro-enteric feeding
tube from soon aCer birth, without parenteral supplementation at
any point.
Comparison: any other feeding regimen, such as delayed initiation
of full milk feeds and gradual advancement of feed volumes while
receiving supplemental fluid or nutrients parenterally.
Types of outcome measures
Primary outcomes
1. In hospital rate of weight gain (g/kg/day) until term equivalent
2. In hospital rate of head circumference growth (cm/week) until
term equivalent
3. Growth restriction: z-score and proportion of infants who remain
below the 10th percentile for the index population distribution
of weight at term equivalent
4. Necrotising enterocolitis, confirmed at surgery or autopsy or
diagnosed by at least two of the following clinical features
(Kliegman 1987)
a. Abdominal radiograph showing pneumatosis intestinalis or
gas in the portal venous system or free air in the abdomen
b. Abdominal distension with abdominal radiograph with
gaseous distension or frothy appearance (or both) of bowel
lumen
c. Blood in stool
d. Lethargy, hypotonia or apnoea (or combination of these)
Secondary outcomes
1. Feed intolerance during the trial intervention period that results
in cessation in enteral feeding for more than four hours
2. Episodes of hypoglycaemia (investigator defined) requiring
treatment with enteral supplement (including milk feed or
buccal dextrose gel) or with intravenous fluids (including
dextrose solution)
3. Invasive infection, as determined by culture of bacteria or fungus
from blood, cerebrospinal fluid, or from a normally sterile body
space
4. Duration of birth hospitalisation (days)
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5. All-cause mortality up to 36 to 44 weeks' post-menstrual age and
one year post-term
6. Growth parameters assessed beyond infancy: weight, height or
head circumference and proportion of infants who remain below
the 10th percentile for the index population's distribution, and
measures of body composition (lean/fat mass) and body mass
index
7. Severe neurodevelopmental disability, assessed beyond infancy
until adulthood: non-ambulant cerebral palsy, developmental
quotient more than two standard deviations below the
population mean and blindness (visual acuity less than 6/60) or
deafness (any hearing impairment requiring or unimproved by
amplification)
Search methods for identification of studies
We will use the standard search strategy of Cochrane Neonatal.
Electronic searches
We will search the Cochrane Central Register of Controlled Trials
(CENTRAL; 2019, current issue), MEDLINE Ovid (1946 to date),
Embase Ovid (1974 to present), Maternity & Infant Care Database
Ovid (1971 to present), and the Cumulative Index to Nursing and
Allied Health Literature (1982 to present), using a combination of
text words and MeSH terms, as described in Appendix 1. We will
limit the search outputs with the relevant search filters for clinical
trials as recommended in the Cochrane Handbook for Systematic
Reviews of Interventions (Higgins 2017). We will not apply any
language restrictions.
We will search ClinicalTrials.gov and the World Health
Organization’s International Clinical Trials Registry Platform
(www.who.int/ictrp/en/), for completed or ongoing trials.
Searching other resources
We will examine the reference lists of studies identified as
potentially relevant. We will search the abstracts from annual
meetings of the Pediatric Academic Societies (1993 to 2019), the
European Society for Paediatric Research (1995 to 2019), the UK
Royal College of Paediatrics and Child Health (2000 to 2019) and
the Perinatal Society of Australia and New Zealand (2000 to 2019).
We will consider trials reported only as abstracts to be eligible if
sufficient information is available from the report, or from contact
with study authors, to fulfil the inclusion criteria (see Dealing with
missing data for further details).
Data collection and analysis
We will use the standard methods of Cochrane Neonatal.
Selection of studies
Two review authors (JB, BC, or VW) will independently screen the
titles and abstracts of all studies and assess the full articles of all
potentially relevant trials. We will exclude those studies that do
not meet all of the inclusion criteria and we will state the reason(s)
for exclusion. We will discuss any disagreements until consensus is
achieved, with referral to WM for a final decision as necessary.
Data extraction and management
Two review authors (JB, BC, or VW) will use a form to independently
extract data on design, methodology, participants, interventions,
outcomes and treatment effects from each included study. We will
discuss any disagreements until we reach a consensus. The data
extraction form will be based on forms used previously by the
author team, with adaptations made to meet the requirements of
this review.
Assessment of risk of bias in included studies
Two review authors (JB, BC, or VW) will independently assess the
risk of bias (low, high, or unclear) of all included trials using the
Cochrane ‘Risk of bias’ tool (Higgins 2017); see Appendix 2 for
details.
We will resolve disagreements by discussion or by including WM for
final decisions. We will not exclude trials on the basis of risk of bias,
but we will conduct sensitivity analyses, if applicable, to explore the
consequences of synthesising evidence of variable quality.
Measures of treatment effect
We will analyse the treatment effects in the individual trials and
report the risk ratio (RR) and risk difference (RD) for dichotomous
data and the mean difference (MD) for continuous data, with 95%
confidence intervals (CIs). We will determine the number needed
to treat for an additional beneficial outcome (NNTB) or number
needed to treat for an additional harmful outcome (NNTH) for
analyses with a statistically significant difference in the RD.
Unit of analysis issues
The unit of analysis will be the participating infant in individually
randomised trials and the neonatal unit (or sub-unit) for cluster-
randomised trials.
For cluster-randomised trials, we will undertake analyses at the
level of the individual while accounting for clustering in the data
using the methods recommended in the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011).
Dealing with missing data
Where data are missing without explanation, and cannot be derived
as described above, we will approach the analysis as follows.
1. Where we have concerns about the extent of missing data or
potential bias in missing data, we will contact the original study
investigators to request the missing data for primary outcomes
only, for studies published within the past 10 years where an
email address is easily available from the published papers.
2. Where possible, we will impute missing standard deviations
(SDs) using the coefficient of variation (CV), or calculate this from
other available statistics including standard errors, confidence
intervals, t values and P values.
3. If the data are assumed to be missing at random, we will analyse
the data without imputing any missing values.
4. If data cannot be assumed to be missing at random then we
will impute the missing outcomes with replacement values,
assuming all to have a poor outcome, and conduct sensitivity
analyses to assess any changes in the direction or magnitude of
effect resulting from data imputation.
Assessment of heterogeneity
Two review authors (JB, VW, or WM) will assess clinical
heterogeneity, and a meta-analysis will only be conducted when
Early full enteral feeding for preterm or low birth weight infants (Protocol)
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both authors agree that study participants, interventions and
outcomes are sufficiently similar.
We will examine the treatment effects of individual trials and
heterogeneity between trial results by inspecting the forest
plots. We will calculate the I2 statistic for each analysis
to quantify inconsistency across studies and describe the
percentage of variability in effect estimates that may be due to
heterogeneity rather than to sampling error. If we detect high
levels of heterogeneity (an I2 value greater than 75%), we will
explore the possible sources (for example, differences in study
design, participants, interventions or completeness of outcome
assessments).
Assessment of reporting biases
If more than 10 trials are included in a meta-analysis, we will
examine a funnel plot for asymmetry.
Data synthesis
We will use the fixed-effect model in Review Manager 5 for meta-
analyses (Review Manager 2014).
Certainty of evidence
We will assess the certainty of the body of evidence for the
main comparisons at the outcomes level using GRADE methods
(Schünemann 2013). Two review authors (JVEB and WM) will
independently assess the certainty of the evidence for the pre-
specified primary outcomes (Primary outcomes). We will consider
evidence from randomised controlled trials as high-certainty but
will downgrade the evidence by one level for serious (or two levels
for very serious) limitations based upon: design (risk of bias),
consistency across studies, directness of the evidence, precision of
estimates, and presence of publication bias. The GRADE approach
results in an assessment of the certainty of the evidence in one of
the following four grades, which we will present in a 'Summary of
findings' table, using GRADEpro GDT.
1. High certainty: we are very confident that the true effect lies
close to that of the estimate of the effect.
2. Moderate certainty: we are moderately confident in the effect
estimate. The true effect is likely to be close to the estimate of the
effect, but there is a possibility that it is substantially different.
3. Low certainty: our confidence in the effect estimate is limited.
The true effect may be substantially different from the estimate
of the effect.
4. Very low certainty: we have very little confidence in the effect
estimate. The true effect is likely to be substantially different
from the estimate of effect.
Subgroup analysis and investigation of heterogeneity
Where data are available, we will undertake the following subgroup
analyses for the primary outcomes.
1. Trials in which infants received human milk only (maternal
expressed breast milk or donor breast milk) versus those where
formula could be given instead of or as a supplement to human
milk
2. Very preterm infants (born at less than 32 weeks' gestation)
versus infants born at 32 weeks' gestation or greater
3. Very low birth weight infants (less than 1500 g) versus infants
with a birth weight of 1500 g or greater
4. Infants with a birth weight below the 10th percentile for the
reference population ('small for gestation') versus infants with
a birth weight at or above the 10th percentile ('appropriate for
gestation')
5. Trials set in low- or middle-income countries
versus trials set in high-income countries




We will undertake sensitivity analyses to determine if the
findings are affected by including only studies of adequate
methodology (low risk of bias), defined as those studies with
adequate randomisation and allocation concealment, blinding of
intervention and measurement, and less than 10% loss to follow-
up.
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A P P E N D I C E S
Appendix 1. Electronic search strategy
Indicative strategy developed and tested for Ovid MEDLINE(R) ALL <1946 to 7 March 07, 2019>
[To be adapted for Embase, Maternity & Infant Care Database (MIDIRS), and CINAHL Plus]
Search Strategy:
--------------------------------------------------------------------------------
1 exp Infant, Newborn/ (579674)
2 Premature Birth/ (11867)
3 (neonat$ or neo nat$).ti,ab. (245905)
4 (newborn$ or new born$ or newly born$).ti,ab. (157152)
5 (preterm or preterms or pre term or pre terms).ti,ab. (67629)
6 (preemie$ or premie or premies).ti,ab. (157)
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7 (prematur$ adj3 (birth$ or born or deliver$)).ti,ab. (14688)
8 (low adj3 (birthweight$ or birth weight$)).ti,ab. (32259)
9 (lbw or vlbw or elbw).ti,ab. (7686)
10 infan$.ti,ab. (409955)
11 (baby or babies).ti,ab. (65499)
12 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 (998371)
13 Enteral Nutrition/ (18635)
14 (enteral adj2 (nutrition or feed$)).ti,ab. (12909)
15 ((oral or sip or tube) adj2 feeding$).ti,ab. (9343)
16 ((nasogastric or gastrostomy or jejunostomy) adj2 tube$).ti,ab. (7950)
17 ((advanc$ or aggressive$ or delay$ or early or fast or full or increas$ or minimal or progress$ or prolonged or rapid$ or routine$ or speed
$ or slow$ or volume$) adj3 enteral feed$).ti,ab. (1497)
18 ((advanc$ or aggressive$ or delay$ or early or fast or full or increas$ or minimal or progress$ or prolonged or rapid$ or routine$ or speed
$ or slow$ or volume$) adj3 enteral nutrition).ti,ab. (1297)
19 ((aggressive$ or fast or rapid$ or slow$ or speed$) adj3 feed$).ti,ab. (2638)
20 ((aggressive$ or fast or rapid$ or slow$ or speed$) adj3 volume$).ti,ab. (3589)
21 trophic feeding$.ti,ab. (85)
22 ((gut or gastrointestinal) adj2 priming).ti,ab. (30)
23 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 (40147)
24 12 and 23 (6420)
25 Parenteral Nutrition/ae [Adverse Effects] (2675)
26 Enterocolitis, Necrotizing/ep, et, pc [Epidemiology, Etiology, Prevention & Control] (1434)
27 ((prevent$ or risk$) adj3 necrotising enterocolitis).ti,ab. (118)
28 ((prevent$ or risk$) adj3 necrotizing enterocolitis).ti,ab. (527)
29 Infection/ep [Epidemiology] (3709)
30 25 or 26 or 27 or 28 or 29 (8110)
31 12 and 30 (2962)
32 24 or 31 (8867)
33 randomized controlled trial.pt. (477193)
34 controlled clinical trial.pt. (92945)
35 randomized.ab. (436251)
36 placebo.ab. (195836)




41 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 (4389362)
42 exp animals/ not humans.sh. (4554122)
43 41 not 42 (3795778)
44 32 and 43 (2483)
--------------------------------------------------------------------------------
Appendix 2. 'Risk of bias' tool
1. Random sequence generation (checking for possible selection bias). Was the allocation sequence adequately generated?
For each included study, we will categorise the method used to generate the allocation sequence as:
• low risk (any truly random process, e.g. random number table; computer random number generator);
• high risk (any non-random process, e.g. odd or even date of birth; hospital or clinic record number); or
• unclear risk.
2. Allocation concealment (checking for possible selection bias). Was allocation adequately concealed?
For each included study, we will categorise the method used to conceal the allocation sequence as:
Early full enteral feeding for preterm or low birth weight infants (Protocol)









Cochrane Database of Systematic Reviews
• low risk (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);
• high risk (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth); or
• unclear risk.
3. Blinding of participants and personnel (checking for possible performance bias). Was knowledge of the allocated intervention
adequately prevented during the study?
For each included study, we will categorise the methods used to blind study participants and personnel from knowledge of which
intervention a participant received. Blinding will be assessed separately for different outcomes or classes of outcomes. We will categorise
the methods as:
• low risk, high risk or unclear risk for participants; and
• low risk, high risk or unclear risk for personnel.
4. Blinding of outcome assessment (checking for possible detection bias). Was knowledge of the allocated intervention adequately
prevented at the time of outcome assessment?
For each included study, we will categorise the methods used to blind outcome assessment. Blinding will be assessed separately for
different outcomes or classes of outcomes. We will categorise the methods as:
• low risk for outcome assessors;
• high risk for outcome assessors; or
• unclear risk for outcome assessors.
5. Incomplete outcome data (checking for possible attrition bias through withdrawals, dropouts, protocol deviations). Were incomplete
outcome data adequately addressed?
For each included study and for each outcome, we will describe the completeness of data including attrition and exclusions from the
analysis. We will note whether attrition and exclusions were reported, the numbers included in the analysis at each stage (compared with
the total randomised participants), reasons for attrition or exclusion (where reported), and whether missing data were balanced across
groups or were related to outcomes. Where sufficient information was reported or supplied by the trial authors, we will re-include missing
data in the analyses. We will categorise the methods as:
• low risk (< 20% missing data);
• high risk (≥ 20% missing data); or
• unclear risk.
6. Selective reporting bias. Are reports of the study free of suggestion of selective outcome reporting?
For each included study, we will describe how we investigated the possibility of selective outcome reporting bias and what we found. For
studies in which study protocols were published in advance, we will compare prespecified outcomes versus outcomes eventually reported
in the published results. If the study protocol was not published in advance, we will contact study authors to gain access to the study
protocol. We will assess the methods as:
• low risk (where it is clear that all of the study's prespecified outcomes and all expected outcomes of interest to the review have been
reported);
• high risk (where not all the study's prespecified outcomes have been reported; one or more reported primary outcomes were not
prespecified outcomes of interest and are reported incompletely and so cannot be used; study fails to include results of a key outcome
that would have been expected to have been reported); or
• unclear risk.
7. Other sources of bias. Was the study apparently free of other problems that could put it at a high risk of bias?
For each included study, we will describe any important concerns we had about other possible sources of bias (for example, whether there
was a potential source of bias related to the specific study design or whether the trial was stopped early due to some data-dependent




If needed, we will explore the impact of the level of bias through undertaking sensitivity analyses.
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